Literature DB >> 21990373

Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration.

Lucy A Clunes1, Catrin M Davies, Raymond D Coakley, Andrei A Aleksandrov, Ashley G Henderson, Kirby L Zeman, Erin N Worthington, Martina Gentzsch, Silvia M Kreda, Deborah Cholon, William D Bennett, John R Riordan, Richard C Boucher, Robert Tarran.   

Abstract

Cigarette smoke (CS) exposure induces mucus obstruction and the development of chronic bronchitis (CB). While many of these responses are determined genetically, little is known about the effects CS can exert on pulmonary epithelia at the protein level. We, therefore, tested the hypothesis that CS exerts direct effects on the CFTR protein, which could impair airway hydration, leading to the mucus stasis characteristic of both cystic fibrosis and CB. In vivo and in vitro studies demonstrated that CS rapidly decreased CFTR activity, leading to airway surface liquid (ASL) volume depletion (i.e., dehydration). Further studies revealed that CS induced internalization of CFTR. Surprisingly, CS-internalized CFTR did not colocalize with lysosomal proteins. Instead, the bulk of CFTR shifted to a detergent-resistant fraction within the cell and colocalized with the intermediate filament vimentin, suggesting that CS induced CFTR movement into an aggresome-like, perinuclear compartment. To test whether airway dehydration could be reversed, we used hypertonic saline (HS) as an osmolyte to rehydrate ASL. HS restored ASL height in CS-exposed, dehydrated airway cultures. Similarly, inhaled HS restored mucus transport and increased clearance in patients with CB. Thus, we propose that CS exposure rapidly impairs CFTR function by internalizing CFTR, leading to ASL dehydration, which promotes mucus stasis and a failure of mucus clearance, leaving smokers at risk for developing CB. Furthermore, our data suggest that strategies to rehydrate airway surfaces may provide a novel form of therapy for patients with CB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990373      PMCID: PMC3290447          DOI: 10.1096/fj.11-192377

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  48 in total

1.  The CF salt controversy: in vivo observations and therapeutic approaches.

Authors:  R Tarran; B R Grubb; D Parsons; M Picher; A J Hirsh; C W Davis; R C Boucher
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

Review 2.  Mucin apoprotein expression in COPD.

Authors:  George D Leikauf; Michael T Borchers; Daniel R Prows; Leigh G Simpson
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

Review 3.  Global initiative for chronic obstructive lung disease.

Authors:  Lynn B Gerald; William C Bailey
Journal:  J Cardiopulm Rehabil       Date:  2002 Jul-Aug       Impact factor: 2.081

4.  The effect of exercise on nasal uptake of ozone in healthy human adults.

Authors:  Keegan Sawyer; James S Brown; Milan J Hazucha; William D Bennett
Journal:  J Appl Physiol (1985)       Date:  2006-11-02

Review 5.  Aggresome formation and neurodegenerative diseases: therapeutic implications.

Authors:  J A Olzmann; L Li; L S Chin
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  Inflammatory reaction and airway damage in cystic fibrosis.

Authors:  A D Barton; K Ryder; R V Lourenço; W Dralle; S G Weiss
Journal:  J Lab Clin Med       Date:  1976-09

7.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

8.  Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Martina Gentzsch; Xiu-Bao Chang; Liying Cui; Yufeng Wu; Victor V Ozols; Amit Choudhury; Richard E Pagano; John R Riordan
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

Review 9.  Inflammation and anti-inflammatory therapies for cystic fibrosis.

Authors:  James F Chmiel; Michael W Konstan
Journal:  Clin Chest Med       Date:  2007-06       Impact factor: 2.878

10.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.

Authors:  David M Mannino; David M Homa; Lara J Akinbami; Earl S Ford; Stephen C Redd
Journal:  MMWR Surveill Summ       Date:  2002-08-02
View more
  124 in total

1.  Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition.

Authors:  Annika B M Åstrand; Martin Hemmerling; James Root; Cecilia Wingren; Jelena Pesic; Edvin Johansson; Alaina L Garland; Arunava Ghosh; Robert Tarran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  Recovery of Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction after Smoking Cessation.

Authors:  Clifford A Courville; S Vamsee Raju; Bo Liu; Frank J Accurso; Mark T Dransfield; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

3.  Mucociliary Clearance in Former Tobacco Smokers with Both Chronic Obstructive Pulmonary Disease and Chronic Bronchitis and the Effect of Roflumilast.

Authors:  Beth L Laube; Kathryn A Carson; Gail Sharpless; Laura M Paulin; Nadia N Hansel
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-04-08       Impact factor: 2.849

4.  The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis.

Authors:  Wayne H Anderson; Raymond D Coakley; Brian Button; Ashley G Henderson; Kirby L Zeman; Neil E Alexis; David B Peden; Eduardo R Lazarowski; C William Davis; Summer Bailey; Fred Fuller; Martha Almond; Bahjat Qaqish; Elena Bordonali; Michael Rubinstein; William D Bennett; Mehmet Kesimer; Richard C Boucher
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

5.  Vaporized E-Cigarette Liquids Induce Ion Transport Dysfunction in Airway Epithelia.

Authors:  Vivian Y Lin; Matthew D Fain; Patricia L Jackson; Taylor F Berryhill; Landon S Wilson; Marina Mazur; Stephen J Barnes; J Edwin Blalock; S Vamsee Raju; Steven M Rowe
Journal:  Am J Respir Cell Mol Biol       Date:  2019-08       Impact factor: 6.914

6.  Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction.

Authors:  Hilaire C Lam; Suzanne M Cloonan; Abhiram R Bhashyam; Jeffery A Haspel; Anju Singh; J Fah Sathirapongsasuti; Morgan Cervo; Hongwei Yao; Anna L Chung; Kenji Mizumura; Chang Hyeok An; Bin Shan; Jonathan M Franks; Kathleen J Haley; Caroline A Owen; Yohannes Tesfaigzi; George R Washko; John Quackenbush; Edwin K Silverman; Irfan Rahman; Hong Pyo Kim; Ashfaq Mahmood; Shyam S Biswal; Stefan W Ryter; Augustine M K Choi
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

Review 7.  Ion Channel Modulators in Cystic Fibrosis.

Authors:  Martina Gentzsch; Marcus A Mall
Journal:  Chest       Date:  2018-05-08       Impact factor: 9.410

8.  Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.

Authors:  S Vamsee Raju; Patricia L Jackson; Clifford A Courville; Carmel M McNicholas; Peter A Sloane; Gina Sabbatini; Sherry Tidwell; Li Ping Tang; Bo Liu; James A Fortenberry; Caleb W Jones; Jeremy A Boydston; J P Clancy; Larry E Bowen; Frank J Accurso; J Edwin Blalock; Mark T Dransfield; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

9.  Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD.

Authors:  Mark T Dransfield; Andrew M Wilhelm; Brian Flanagan; Clifford Courville; Sherry L Tidwell; S Vamsee Raju; Amit Gaggar; Chad Steele; Li Ping Tang; Bo Liu; Steven M Rowe
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

10.  Acute effects of cigarette smoke extract on alveolar epithelial sodium channel activity and lung fluid clearance.

Authors:  Charles A Downs; Lisa H Kreiner; David Q Trac; My N Helms
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.